Exact Sciences Corporation (NASDAQ:EXAS) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ET
Company Participants
Derek Leckow – Vice President, Investor Relations
Kevin Conroy – Chairman and Chief Executive Officer
Aaron Bloomer – Chief Financial Officer
Brian Baranick – General Manager, Precision Oncology
Conference Call Participants
Catherine Schulte – Baird
Doug Schenkel – Wolfe Research
Tycho Peterson – Jefferies
Matt Sykes – Goldman Sachs
Dan Brennan – TD Cowen
Jack Meehan – Nephron Research
Andrew Brackmann – William Blair
Patrick Donnelly – Citi
Vijay Kumar – Evercore ISI
Subu Nambi – Guggenheim Securities
Puneet Souda – Leerink Partners
Dan Leonard – UBS
Bill Bonello – Craig Hallum
Sung Ji Nam – Scotiabank
Eve Burstein – Bernstein Research
Andrew Cooper – Raymond James
Kyle Mikson – Canaccord
Operator
Good day, everyone, and welcome to the Exact Sciences Fourth Quarter 2024 Earnings Call. Today’s call is being recorded. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. [Operator Instructions]
I would now like to turn the conference over to Derek Leco, Vice President Investor Relations. Please go ahead, sir.
Derek Leckow
Thanks, operator. Thank you for joining us for Exact Sciences fourth quarter 2024 conference call. On the call today are Kevin Conroy, the company’s Chairman and CEO, and Aaron Bloomer, our Chief Financial Officer; Brian Baranick, our General Manager of Precision Oncology, will also be available for questions.
Exact Sciences issued a news release earlier this afternoon detailing our fourth quarter financial results. This news release and today’s presentation are available on our website at exactsciences.com. During today’s call, we will make forward-looking statements based on current expectations. Our actual results may be materially different from such statements. Discussions of non-GAAP figures and reconciliations to GAAP figures are available in our